Cargando…
Type I interferon: From innate response to treatment for COVID‐19
Effective prophylactic and therapeutic interventions are urgently needed to address the coronavirus disease 2019 (COVID‐19) pandemic. Various antiviral drugs have recently been tested. Type I interferon (IFN) is a regulatory protein involved in the innate immune response, with broad‐spectrum antivir...
Autores principales: | Lin, Fuyu, Shen, Kunling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768291/ https://www.ncbi.nlm.nih.gov/pubmed/33376955 http://dx.doi.org/10.1002/ped4.12226 |
Ejemplares similares
-
Crosstalk between Autophagy and Type I Interferon Responses in Innate Antiviral Immunity
por: Tian, Yu, et al.
Publicado: (2019) -
TRIMming Type I Interferon-Mediated Innate Immune Response in Antiviral and Antitumor Defense
por: Wang, Ling, et al.
Publicado: (2021) -
The type I interferon response in COVID-19: implications for treatment
por: Lee, Jeong Seok, et al.
Publicado: (2020) -
Type I Interferons in COVID-19 Pathogenesis
por: Palermo, Enrico, et al.
Publicado: (2021) -
Dysregulation of type I interferon responses in COVID-19
por: Acharya, Dhiraj, et al.
Publicado: (2020)